SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-17-006829
Filing Date
2017-04-21
Accepted
2017-04-21 13:46:47
Documents
5
Effectiveness Date
2017-04-21

Document Format Files

Seq Description Document Type Size
1 DEFA14A albo-defa14a_20170609.htm DEFA14A 104041
2 GRAPHIC g201704200107015046513.jpg GRAPHIC 39987
3 GRAPHIC g201704200107001886511.jpg GRAPHIC 117092
4 GRAPHIC g201704200107001636510.jpg GRAPHIC 84714
5 GRAPHIC g201704200107014866512.jpg GRAPHIC 52053
  Complete submission text file 0001564590-17-006829.txt   510390
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33451 | Film No.: 17775181
SIC: 2834 Pharmaceutical Preparations